Junhe Li

1.2k total citations · 1 hit paper
31 papers, 795 citations indexed

About

Junhe Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junhe Li has authored 31 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Junhe Li's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Junhe Li is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Junhe Li collaborates with scholars based in China, United States and South Korea. Junhe Li's co-authors include Jianping Xiong, Jun Deng, Ling Zhang, Xiaojun Xiang, Jun Chen, Lei Wan, Shanshan Huang, Fang Wu, Yangyang Yao and Hui Guo and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Junhe Li

31 papers receiving 792 citations

Hit Papers

Durvalumab plus gemcitabine and cisplatin in advanced bil... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
    2024 51 citations Howard A. Burris, Takuji Okusaka et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhe Li China 17 560 342 172 99 98 31 795
Xin Song China 16 662 1.2× 385 1.1× 211 1.2× 61 0.6× 120 1.2× 31 921
Tianli Fan China 14 609 1.1× 391 1.1× 167 1.0× 65 0.7× 92 0.9× 29 832
Zhangqian Chen China 14 700 1.3× 421 1.2× 227 1.3× 78 0.8× 115 1.2× 19 961
Vijesh Kumar Yadav Taiwan 18 502 0.9× 310 0.9× 173 1.0× 62 0.6× 147 1.5× 41 814
Sheng Zhou China 12 452 0.8× 380 1.1× 135 0.8× 122 1.2× 114 1.2× 20 748
Wuguo Li China 16 569 1.0× 272 0.8× 192 1.1× 53 0.5× 78 0.8× 31 842
Mingde Zang China 14 457 0.8× 206 0.6× 211 1.2× 82 0.8× 104 1.1× 21 732
Bo Yin China 19 573 1.0× 330 1.0× 219 1.3× 73 0.7× 169 1.7× 43 873

Countries citing papers authored by Junhe Li

Since Specialization
Citations

This map shows the geographic impact of Junhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhe Li more than expected).

Fields of papers citing papers by Junhe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhe Li. The network helps show where Junhe Li may publish in the future.

Co-authorship network of co-authors of Junhe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junhe Li. A scholar is included among the top collaborators of Junhe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhe Li. Junhe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burris, Howard A., Takuji Okusaka, Arndt Vogel, et al.. (2024). Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 25(5). 626–635. 51 indexed citations breakdown →
2.
3.
Yao, Yangyang, Zhen Liu, Shanshan Huang, et al.. (2022). The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway. Cell Death Discovery. 8(1). 79–79. 32 indexed citations
4.
Li, Qiurong, Pengfei Tang, Panpan Zhang, et al.. (2022). Inhibition of the P2X7/NLRP3 Inflammasome Signaling Pathway by Deacetylgedunin from Toona sinensis. Journal of Natural Products. 85(5). 1388–1397. 5 indexed citations
5.
Li, Junhe, Wei Huang, Qing Han, Jianping Xiong, & Zhiwang Song. (2021). LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway. Medical Oncology. 38(1). 2–2. 7 indexed citations
6.
Guo, Hui, Jian‐Ping Zou, Ling Zhou, et al.. (2021). NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein. Frontiers in Oncology. 10. 591698–591698. 30 indexed citations
7.
Yu, Yi, et al.. (2020). Exendin‐4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation. The Prostate. 80(5). 367–375. 22 indexed citations
8.
Huang, Shanshan, Yuan Cao, Hui Guo, et al.. (2020). Up‐regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1‐AGK–positive loop. Journal of Cellular and Molecular Medicine. 24(19). 11133–11145. 13 indexed citations
9.
Li, Li, Shanshan Huang, Yangyang Yao, et al.. (2020). Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. World Journal of Surgical Oncology. 18(1). 324–324. 16 indexed citations
10.
Zhu, Lingling, Shanshan Huang, Junhe Li, et al.. (2020). Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways. Gene. 742. 144556–144556. 33 indexed citations
11.
Han, Qing, Junhe Li, Jianping Xiong, & Zhiwang Song. (2020). Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. Journal of Experimental & Clinical Cancer Research. 39(1). 151–151. 38 indexed citations
12.
13.
Li, Junhe, et al.. (2019). UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.. PubMed. 9(9). 1970–1981. 43 indexed citations
14.
Chen, Xuanying, et al.. (2019). miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway. Toxicology Research. 8(6). 875–884. 9 indexed citations
15.
Li, Junhe, et al.. (2018). Exendin‐4 enhances radiation response of prostate cancer. The Prostate. 78(15). 1125–1133. 13 indexed citations
16.
Luo, Jie, Yuan‐Zheng Xia, Jun Luo, et al.. (2017). GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma. Cancer Letters. 410. 112–123. 35 indexed citations
17.
Luo, Jun, et al.. (2016). Two rare limonoids from the stem barks of Entandrophragma utile. Tetrahedron Letters. 57(48). 5334–5337. 8 indexed citations
18.
Deng, Jun, et al.. (2013). Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro. Biochemical and Biophysical Research Communications. 443(3). 789–795. 102 indexed citations
19.
Li, Zhengrong, Yi Cao, Zhigang Jie, et al.. (2012). miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Letters. 323(1). 41–47. 89 indexed citations
20.
Liu, Xiaohui, et al.. (2012). Effects of over-expression of ANXA10 gene on proliferation and apoptosis of hepatocellular carcinoma cell line HepG2. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(5). 669–674. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Tianli Fan Breakdown of academic impact, for papers by Zhangqian Chen Breakdown of academic impact, for papers by Vijesh Kumar Yadav Breakdown of academic impact, for papers by Sheng Zhou Breakdown of academic impact, for papers by Wuguo Li Breakdown of academic impact, for papers by Mingde Zang Breakdown of academic impact, for papers by Bo Yin
Rankless by CCL
2026